長江健康(002435.SZ):”奧美拉唑腸溶膠囊“擬中標全國藥品集採
格隆匯 8 月 20日丨長江健康(002435.SZ)公佈,2020年8月20日,長江潤髮健康產業股份有限公司(以下簡稱“公司”)旗下海南海靈化學制藥有限公司(以下簡稱“海靈藥業”)參加了國家組織藥品集中採購和使用聯合採購辦公室(以下簡稱“聯採辦”)組織的第三批全國藥品集中採購工作。海靈藥業已獲得國家藥品監督管理局仿製藥質量和療效一致性評價的藥品奧美拉唑腸溶膠囊(20mg/粒)擬中選本次集中採購。
本次集中採購是國家組織的第三批藥品集中帶量採購,採購週期中,醫療機構將優先使用本次藥品集中採購中選藥品,並確保完成約定採購量。本次公司產品擬中選價格具體以聯採辦公佈的價格為準。若公司後續簽訂採購合同並實施後,將有利於進一步擴大相關產品的銷售,提高市場佔有率,促進公司相關產品國內市場的開拓,夯實公司在消化類藥品領域的市場地位,對公司的未來經營業績產生積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.